Presentations from 36th Annual International Prostate Cancer Update
Welcome and Opening Remarks
John W. Davis, MD, FACS, welcomed attendees to the 36th Annual International Prostate Cancer Update on February 1, 2026, in Vail, Colorado.
Where Will Artificial Intelligence Impact Prostate Cancer Diagnostics and Therapy?
David M. Albala, MD, presented this lecture during the 36th Annual International Prostate Cancer Update on February 1, 2026, in Vail, Colorado.
Promising Advances from Industry: Diagnostics, Devices, and Therapy
Christian P. Pavlovich, MD, presented this lecture during the 36th Annual International Prostate Cancer Update on February 1, 2026, in Vail, Colorado.
Panel Discussion Session 1: TechCon: AI and Novel Technologies in Prostate Cancer
David M. Albala, MD, and Christian P. Pavlovich, MD, had a panel discussion during the 36th Annual International Prostate Cancer Update on February 1, 2026, in Vail, Colorado.
Navigating the Management of mCSPC from Mono to Quadruple Therapies
E. David Crawford, MD, presented this lecture during the 36th Annual International Prostate Cancer Update on February 1, 2026, in Vail, Colorado.
Navigating Hormone Therapy in Prostate Cancer: Strategies to Reduce Side Effects and Prolong Survival
Laurence Klotz, MD, presented this lecture during the 36th Annual International Prostate Cancer Update on February 1, 2026, in Vail, Colorado.
Rescuing ADT and ARPI: Benefits from Toxicities
Andrew W. Hahn, MD, presented this lecture during the 36th Annual International Prostate Cancer Update on February 1, 2026, in Vail, Colorado.
When Not to Treat with Androgen Deprivation Therapy
Mary-Ellen Taplin, MD, presented this lecture during the 36th Annual International Prostate Cancer Update on February 1, 2026, in Vail, Colorado.
Panel Discussion for Session 2: Navigating the Challenges of ADT
E. David Crawford, MD, moderated this panel discussion during the 36th Annual International Prostate Cancer Update on February 1, 2026, in Vail, Colorado.
Optimal Patient Selection and Exclusion for MTI
David Albala, MD, presented this lecture during the 36th Annual International Prostate Cancer Update on February 2, 2026, in Vail, Colorado.
Novel Indications for Molecular Targeted Imaging (Focus on PSMA PET)
Scott T. Tagawa, MS, FACP, presented this lecture during the 36th Annual International Prostate Cancer Update on February 2, 2026, in Vail, Colorado.
Emerging Molecular Targeted Imaging Agents
Robert E. Reiter, MD, presented this lecture during the 36th Annual International Prostate Cancer Update on February 2, 2026, in Vail, Colorado.
Borderline Molecular Targeted Imaging Results: Case Studies
Brian T. Helfand, MD, PhD, presented this lecture during the 36th Annual International Prostate Cancer Update on February 2, 2026, in Vail, Colorado.
Panel Discussion: MTI
Robert E. Reiter, MD, moderated this panel discussion during the 36th Annual International Prostate Cancer Update on February 2, 2026, in Vail, Colorado.
PSA Screening in 2026: Updates on MRI and Adjunct Biomarkers Use
Yaw A. Nyame, MD, presented this lecture during the 36th Annual International Prostate Cancer Update on February 2, 2026, in Vail, Colorado.
Elevated PSA with Prior Negative Biopsy: When to Repeat versus Observe
Matthew R. Cooperberg, MD, MPH, presented this lecture during the 36th Annual International Prostate Cancer Update on February 2, 2026, in Vail, Colorado.
Genomic Testing: Current Value in the Era of MRI and Clinical Prognostic Factors
Matthew R. Cooperberg, MD, MPH, presented this lecture during the 36th Annual International Prostate Cancer Update on February 2, 2026, in Vail, Colorado.
Panel Discussion
John W. Davis, MD, FACS, moderated this panel discussion during the 36th Annual International Prostate Cancer Update on February 2, 2026, in Vail, Colorado.
RARP Semi-Live Presentation
John W. Davis, MD, FACS, presented this lecture during the 36th Annual International Prostate Cancer Update on February 2, 2026, in Vail, Colorado.
Genetic Testing: Utility Through the Disease Life Cycle
Brian T. Helfand, MD, PhD, presented this lecture during the 36th Annual International Prostate Cancer Update on February 2, 2026, in Vail, Colorado.
The Role of the Pathologist in the Selection and Monitoring of Patients for Active Surveillance
M. Scott Lucia, MD, presented this lecture during the 36th Annual International Prostate Cancer Update on February 2, 2026, in Vail, Colorado.
Use of Biomarkers: Genomic Testing to Delete ADT with Radiation
Jonathan D. Tward, MD, PhD, FASTRO, presented this lecture during the 36th Annual International Prostate Cancer Update on February 2, 2026, in Vail, Colorado.
Update on Racial Disparities in PSA Screening and Detection
Yaw A. Nyame, MD, MS, MBA , presented this lecture during the 36th Annual International Prostate Cancer Update on February 2, 2026, in Vail, Colorado.
Panel Discussion
John W. Davis, MD, FACS, moderated this Panel Discussion on Germline, Molecular Detection, and Screening during the 36th Annual International Prostate Cancer Update on February 2, 2026, in Vail, Colorado.
Day 2 Welcome Remarks
Peter F. Orio III, DO, MS, presented this lecture during the 36th Annual International Prostate Cancer Update on February 3, 2026, in Vail, Colorado.
RARP Checklist for Early Career Efficiency and Troubleshooting Skills
John W. Davis, MD, FACS, presented this lecture during the 36th Annual International Prostate Cancer Update on February 3, 2026, in Vail, Colorado.
Current and Planned NRG Prostate Cancer Trials
Jeff M. Michalski, MD, MBA, presented this lecture during the 36th Annual International Prostate Cancer Update on February 3, 2026, in Vail, Colorado.
Salvage Post Radiation: When Can More Radiation Be Offered
Steven J. Frank, MD, presented this lecture during the 36th Annual International Prostate Cancer Update on February 3, 2026, in Vail, Colorado.
MRI-Assisted Radiosurgery (MARS) for LDR/HDR/EBRT for Prostate Cancer Treatment
Steven J. Frank, MD, presented this lecture during the 36th Annual International Prostate Cancer Update on February 3, 2026, in Vail, Colorado.
Panel Discussion Approaches in Localized Prostate Cancer
Peter F. Orio III, DO, MS, moderated this Panel Discussion on Germline, Molecular Detection, and Screening during the 36th Annual International Prostate Cancer Update on February 3, 2026, in Vail, Colorado.
Brian J. Moran Distinguished Lecture
Grgur S. Mirić, MD, FACR, FABS, presented this lecture during the 36th Annual International Prostate Cancer Update on February 3, 2026, in Vail, Colorado.
Focal Therapy for Prostate Cancer and Urologic Oncology: Friend or Foe
Behfar Ehdaie, MD, MPH, presented this lecture during the 36th Annual International Prostate Cancer Update on February 3, 2026, in Vail, Colorado.
Salvage RARP Post Ablation
John W. Davis, MD, presented this lecture during the 36th Annual International Prostate Cancer Update on February 3, 2026, in Vail, Colorado.
Case Discussions: Cases I Try to Avoid
Behfar Ehdaie, MD, MPHS, moderated this Case Discussion during the 36th Annual International Prostate Cancer Update on February 3, 2026, in Vail, Colorado.
Rethinking Focal Therapy: Whole-Gland Ablation for Select Patients
Abhinav Sidana, MBBS, MPH, presented this lecture during the 36th Annual International Prostate Cancer Update on February 3, 2026, in Vail, Colorado.
Panel Discussion: Focal Therapy for Prostate Cancer
Behfar Ehdaie, MD, MPHS, moderated this Panel Discussion on Focal Therapy for Prostate Cancer during the 36th Annual International Prostate Cancer Update on February 3, 2026, in Vail, Colorado.
Selection and Management for Locally Advanced Disease Declining Clinical Trials
Mary-Ellen Taplin, MD, presented this lecture during the 36th Annual International Prostate Cancer Update on February 3, 2026, in Vail, Colorado.
What to do with Positive PSMA-PET Detected Nodes?
Christian P. Pavlovich, MD, presented this lecture during the 36th Annual International Prostate Cancer Update on February 3, 2026, in Vail, Colorado.
High Resolution Micro Ultrasound: Can It Replace MRI?
Laurence Klotz, MD, presented this lecture during the 36th Annual International Prostate Cancer Update on February 3, 2026, in Vail, Colorado.
A Look At Oligometastatic Disease: Metastasis-Directed Therapy versus Systematic
Jonathan D. Tward, MD, PhD, presented this lecture during the 36th Annual International Prostate Cancer Update on February 3, 2026, in Vail, Colorado.
Panel Discussion: High Risk Localized and Oligometastatic Disease
Jonathan D. Tward, MD, PhD, moderated this Panel Discussion during the 36th Annual International Prostate Cancer Update on February 3, 2026, in Vail, Colorado.
MTI in Biochemical Recurrent Disease: What Threshold, Which Images?
Peter F. Orio III, DO, MS, presented this lecture during the 36th Annual International Prostate Cancer Update on February 3, 2026, in Vail, Colorado.
Salvage Therapy: Treat Immediately or Observe?
Peter J. Rossi, MD, presented this lecture during the 36th Annual International Prostate Cancer Update on February 3, 2026, in Vail, Colorado.
Salvage Nodal Radiotherapy in the PET Era: Long-Term Outcomes
Brian J. Davis, MD, PhD, presented this lecture during the 36th Annual International Prostate Cancer Update on February 3, 2026, in Vail, Colorado.
Biomarkers in Advanced Disease
Mary-Ellen Taplin, MD, presented this lecture during the 36th Annual International Prostate Cancer Update on February 3, 2026, in Vail, Colorado.
Panel Discussion: Advanced Prostate Cancer: Part 1
Brian J. Davis, MD, PhD, moderated this Panel Discussion during the 36th Annual International Prostate Cancer Update on February 3, 2026, in Vail, Colorado.
Practical Selection for Doublet versus Triplet Therapy
Daniel P. Petrylak, MD, presented this lecture during the 36th Annual International Prostate Cancer Update on February 4, 2026, in Vail, Colorado.
Avoiding Monotherapy: Any Progress?
Andrew W. Hahn, MD, presented this lecture during the 36th Annual International Prostate Cancer Update on February 4, 2026, in Vail, Colorado.
Radioligand Therapy Updates
Robert E. Reiter, MD, presented this lecture during the 36th Annual International Prostate Cancer Update on February 4, 2026, in Vail, Colorado.
Alternate Therapy Updates
Daniel P. Petrylak, MD, presented this lecture during the 36th Annual International Prostate Cancer Update on February 4, 2026, in Vail, Colorado.
Panel Discussion: Advanced Prostate Cancer: Part 2
Daniel P. Petrylak, MD, moderated this Panel Discussion during the 36th Annual International Prostate Cancer Update on February 4, 2026, in Vail, Colorado.
Early Detection Saves Lives: PCEC’s Mission to Expand PSA Screening
Molly Turner, presented this lecture during the 36th Annual International Prostate Cancer Update on February 4, 2026, in Vail, Colorado.
The Undecided PCA Consult: Optimized Counseling, Treatment Choices, and Avoiding Decision Regret
Jonathan D. Tward, MD, PhD, FASTRO, presented this lecture during the 36th Annual International Prostate Cancer Update on February 4, 2026, in Vail, Colorado.
Expert Panel on the Status of Clinical Trials
Peter F. Orio III, DO, MS, moderated this Expert Panel during the 36th Annual International Prostate Cancer Update on February 4, 2026, in Vail, Colorado.